Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
1.
Sustainability ; 14(8):4399, 2022.
Article in English | MDPI | ID: covidwho-1785959

ABSTRACT

This study analyzed 350 companies based in the Śląskie Province that received financial aid to avoid the negative impacts of COVID-19. This study focused on the structure of companies receiving public support due to their business being at risk of negative impacts from the COVID-19 pandemic in terms of the amount and type of support. It also classified industries by the amount of subsidy. When analyzing the available data, the Kruskal–Wallis test was applied, which is a nonparametric equivalent of the one-way analysis of variance. It was used to test whether the selected factors significantly affect the values of individual measures. Although the amounts of subsidies received vary, they have contributed to preserving at-risk jobs due to the public health crisis and maintaining the competitiveness of affected micro-, small and medium-sized enterprises (SMEs).

2.
Am J Trop Med Hyg ; 102(6): 1208-1209, 2020 06.
Article in English | MEDLINE | ID: covidwho-107974

ABSTRACT

The early shortage of novel coronavirus disease (COVID-19) tests in the United States led many hospitals to first screen for common respiratory pathogens, and only if this screen was negative to proceed with COVID-19 testing. We report a case of a 56-year-old woman with severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) coinfection with group A Streptococcus. The initial testing strategy resulted in delays in both diagnosis and implementation of appropriate precautions. Underlined is the importance of testing for both SARS-CoV-2 and other common respiratory pathogens during the current pandemic.


Subject(s)
Betacoronavirus/pathogenicity , Chronic Pain/diagnostic imaging , Coronavirus Infections/diagnostic imaging , Hypertension/diagnostic imaging , Lung/diagnostic imaging , Pneumonia, Viral/diagnostic imaging , Streptococcal Infections/diagnostic imaging , Antibodies, Monoclonal, Humanized/therapeutic use , Azithromycin/therapeutic use , Betacoronavirus/drug effects , Betacoronavirus/isolation & purification , COVID-19 , Ceftriaxone/therapeutic use , Chicago , Chronic Pain/immunology , Chronic Pain/pathology , Chronic Pain/therapy , Coinfection , Coronavirus Infections/immunology , Coronavirus Infections/pathology , Coronavirus Infections/therapy , Extracorporeal Membrane Oxygenation , Female , Humans , Hydroxychloroquine/therapeutic use , Hypertension/immunology , Hypertension/pathology , Hypertension/therapy , Lung/drug effects , Lung/pathology , Lung/virology , Middle Aged , Pandemics , Pneumonia, Viral/immunology , Pneumonia, Viral/pathology , Pneumonia, Viral/therapy , SARS-CoV-2 , Streptococcal Infections/immunology , Streptococcal Infections/pathology , Streptococcal Infections/therapy , Streptococcus pyogenes/drug effects , Streptococcus pyogenes/isolation & purification , Streptococcus pyogenes/pathogenicity , Tomography, X-Ray Computed , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL